Inventor profile of:

Mark E. Salvati

City:

Lawrenceville, New Jersey

Country:

United States

Published Applications:

23

Last publication date:

2012-12-20

Top Assignees for applications by Mark E. Salvati

The entities that hold a legal rights for patent applications filed by inventor Salvati Mark E.:

Recent patent applications by Salvati Mark E.

Mark E. Salvati from Lawrenceville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-12-20
US20120322761A1
Chemistry; metallurgy

Heterocyclic CETP inhibitors

#2 | 2010-10-21
US20100267669A1
Chemistry; metallurgy

Heterocyclic CETP inhibitors

#3 | 2007-07-12
US20070161685A1
Chemistry; metallurgy

Heterocyclic CETP inhibitors

#4 | 2007-06-14
US20070135631A1
Chemistry; metallurgy

Heterocyclic CETP inhibitors

#5 | 2007-05-29
US10878851
-

Crystallographic structure of the androgen receptor ligand binding domain

#6 | 2007-04-19
US20070088039A1
Chemistry; metallurgy

Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function

#7 | 2007-04-19
US20070088029A1
Chemistry; metallurgy

Tricycloundecane compounds useful as modulators of nuclear hormone receptor function

#8 | 2006-11-23
US20060264459A1
Chemistry; metallurgy

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#9 | 2006-10-05
US20060223832A1
Chemistry; metallurgy

Fused heterocyclic imido and amido compounds

#10 | 2006-08-08
US10322276
-

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

#11 | 2006-05-25
US20060111424A1
Human necessities

Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#12 | 2006-02-21
US10322306
-

Fused cyclic modulators of nuclear hormone receptor function

#13 | 2006-01-31
US10685020
-

Bicyclic modulators of androgen receptor function

#14 | 2006-01-26
US20060020002A1
Chemistry; metallurgy

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

#15 | 2005-12-22
US20050282813A1
Chemistry; metallurgy

Fused cyclic modulators of nuclear hormone receptor function

#16 | 2005-12-08
US20050272799A1
Chemistry; metallurgy

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#17 | 2005-11-17
US20050256048A1
Chemistry; metallurgy

Selective androgen receptor modulators and methods for their identification, design and use

#18 | 2005-11-01
US9885827
-

Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator

#19 | 2005-09-01
US20050192253A1
Chemistry; metallurgy

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#20 | 2005-08-25
US20050187273A1
Chemistry; metallurgy

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

#21 | 2005-06-09
US20050124625A1
Chemistry; metallurgy

Piperazine derivatives and their use as modulators of nuclear hormone receptor function

#22 | 2005-06-02
US20050119228A1
Chemistry; metallurgy

Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof

#23 | 2005-05-24
US10639272
-

Process for preparing azacycloalkanoylaminothiazoles (LD 137e)

InventorID:

3317907 ⎘